Description
Semax 5 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product on this listing.
Research-grade synthetic heptapeptide supplied as a 5 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Identification
| Product name | Semax |
| Also listed as | ACTH(4–7) analogue with Pro-Gly-Pro C-terminus |
| Supplier | Opti-Gen Peptides |
| Contents | 5 mg per vial |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| CAS | 80714-61-0 |
| Formula | C₃₇H₅₁N₉O₁₀S |
| Approx. mass | ~814 Da |
| Class | Synthetic heptapeptide |
| Intended use | Laboratory / in-vitro research only |
Not Selank or Adamax.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation, nasal or injection instructions on this page.
Published research context (not product claims)
Semax was developed from ACTH fragment chemistry as Met-Glu-His-Phe-Pro-Gly-Pro. Papers describe it as a melanocortin-related research peptide used in CNS-signalling, neurotrophin-expression and ischaemia models.
A separate body of Russian clinical literature exists for authorised local Semax products. Those authorisations do not apply to this research vial and do not make it a UK medicine.
Adamax and other catalogue analogues are not this compound. Do not treat analogue marketing as Semax evidence.
There is no MHRA marketing authorisation for this listing. Nootropic, stroke or nasal-spray claims are not permitted on this page.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.